human lymphoblast cell line Search Results


94
OriGene human jurkat t cell cdna library
Human Jurkat T Cell Cdna Library, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/Jurkat+(Human+T+cell+lymphoblast-like+cell+line)+Whole+Cell+Lysate/pmc02747983-69-1-22
Average 94 stars, based on 1 article reviews
human jurkat t cell cdna library - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
ALTANA Inc human t lymphoblast cell line ccrf vcr1000
Human T Lymphoblast Cell Line Ccrf Vcr1000, supplied by ALTANA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/human+t+lymphoblast+cell+line+ccrf+vcr1000/pm31917466-212-1-29
Average 90 stars, based on 1 article reviews
human t lymphoblast cell line ccrf vcr1000 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioResource International Inc human b lymphoblastic leukemia cell line tanoue
Human B Lymphoblastic Leukemia Cell Line Tanoue, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/human+b+lymphoblastic+leukemia+cell+line+tanoue/pm24920488-29-1-13
Average 90 stars, based on 1 article reviews
human b lymphoblastic leukemia cell line tanoue - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
SYNLAB International GmbH human lymphoblastic leukemia cell line rs4;11
Human Lymphoblastic Leukemia Cell Line Rs4;11, supplied by SYNLAB International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/human+lymphoblastic+leukemia+cell+line+rs4+11/pmc11061151-95-2-12
Average 90 stars, based on 1 article reviews
human lymphoblastic leukemia cell line rs4;11 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
EuroClone human t-lymphoblastic leukemic cem cell line
Human T Lymphoblastic Leukemic Cem Cell Line, supplied by EuroClone, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/human+t+lymphoblastic+leukemic+cem+cell+line/pm21132263-52-1-12
Average 90 stars, based on 1 article reviews
human t-lymphoblastic leukemic cem cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Trenzyme Inc raji human lymphoblast-like cell line
ADCP activity of sabatolimab in vitro . (A) THP-1 cells (TIM-3 sufficient, control, or TIM-3 deficient, KO) were cultured for 1 hour with <t>Raji</t> TIM-3 o.e. cells and treated with different concentrations of sabatolimab or hIgG4 isotype control in duplicates. ADCP was determined by flow cytometric analysis as % of CFSE + CD11c + cells. Plots depict means ± SD for each condition. (B) THP-1 cells (TIM-3 sufficient, control, or TIM-3 deficient, KO) cultured as in A with with Raji hTIM-3 o.e. cells were treated with sabatolimab or hIgG4 isotype control, with Latrunculin A or Fc-blocking antibody added to some of the wells in duplicates. ADCP was determined by flow cytometric analysis as % of CFSE + CD11c + cells. Plots depict means ± SD for each condition. (C,D) Macrophages differentiated from PBMC-isolated monocytes were cultured for 4 hours with CFSE-labeled leukemia cells (HNT-34, in C or SKM-1, in D) and treated with different concentrations of sabatolimab or hIgG4 isotype control in duplicates. ADCP was determined by flow cytometric analysis as % of CFSE + CD11c + cells. Plots depict means ± SD for each condition. Two separate donors are shown for each cell line. Asterisks mark statistically significant P values between sabatolimab- and isotype control-treated samples ( T test * P < 0.05, ** P < 0.005, *** P < 0.001).
Raji Human Lymphoblast Like Cell Line, supplied by Trenzyme Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/raji+human+lymphoblast+like+cell+line/pmc09525012-71-1-42
Average 90 stars, based on 1 article reviews
raji human lymphoblast-like cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
JCRB Cell Bank human lymphoblast cell line tk6
Differentially expressed proteins (DEP) identified in <t>TK6</t> cells exposed to 4-nitroanthranilic acid. a A total of 1078 DEPs that differentially expressed compared to control groups were identified based on a log 2 fold change of ≥2. Effects of treatment time are greater than that of dose. b A total of 168 specific DEPs that differentially expressed compared to other groups were further extracted from the 420 DEPs in 24 h 800 μg/mL group based on a log 2 fold change of ≥1
Human Lymphoblast Cell Line Tk6, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/human+lymphoblast+cell+line+tk6/pmc07937321-152-1-10
Average 90 stars, based on 1 article reviews
human lymphoblast cell line tk6 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Piedmont Research Center human acute lymphoblastic leukemia cell line molt-4
Differentially expressed proteins (DEP) identified in <t>TK6</t> cells exposed to 4-nitroanthranilic acid. a A total of 1078 DEPs that differentially expressed compared to control groups were identified based on a log 2 fold change of ≥2. Effects of treatment time are greater than that of dose. b A total of 168 specific DEPs that differentially expressed compared to other groups were further extracted from the 420 DEPs in 24 h 800 μg/mL group based on a log 2 fold change of ≥1
Human Acute Lymphoblastic Leukemia Cell Line Molt 4, supplied by Piedmont Research Center, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/human+acute+lymphoblastic+leukemia+cell+line+molt+4/us08269009-2044-0-10
Average 90 stars, based on 1 article reviews
human acute lymphoblastic leukemia cell line molt-4 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CEM Corporation human lymphoblast cell line carrying 1 copy of integrated lv.gfp
Differentially expressed proteins (DEP) identified in <t>TK6</t> cells exposed to 4-nitroanthranilic acid. a A total of 1078 DEPs that differentially expressed compared to control groups were identified based on a log 2 fold change of ≥2. Effects of treatment time are greater than that of dose. b A total of 168 specific DEPs that differentially expressed compared to other groups were further extracted from the 420 DEPs in 24 h 800 μg/mL group based on a log 2 fold change of ≥1
Human Lymphoblast Cell Line Carrying 1 Copy Of Integrated Lv.Gfp, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/human+lymphoblast+cell+line+carrying+1+copy+of+integrated+lv+gfp/pmc08190599__mmc2-791-21-15
Average 90 stars, based on 1 article reviews
human lymphoblast cell line carrying 1 copy of integrated lv.gfp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Coriell Institute for Medical Research human patient lymphoblast cell line gm11860
CFTR c.3718-2477C>T aberrant splicing and correction with a splice-switching antisense oligonucleotide. ( A ) Schematic of the aberrant splicing caused by the CFTR c.3718-2477C>T mutation in intron 22. The C>T mutation creates a de novo 5′ splice site resulting in the insertion into the mRNA of an 84 nucleotide pseudoexon (ψ-Ex) that has an in-frame stop codon. An ASO designed to mask the CFTR c.3718-2477C>T de novo splice site redirects splicing to the canonical splice site, restoring wild-type (WT) mRNA. ( B ) Sequence alignment of ASO-ψ to the ψ-Ex 5′ splice site found in CFTR c.3718-2477C>T. ( C ) RT-PCR analysis of CFTR splicing in a <t>lymphoblast</t> cell line from a CF patient homozygous for the CFTR c.3718-2477C>T mutation following transfection with vehicle only (–), a control, non-targeted ASO (ASO-C) or ASO-ψ targeting the ψ-Ex 5′ splice site. Cells were untreated (−) or treated (+) with puromycin before RNA isolation. GAPDH was analyzed as a control for total cellular RNA abundance. Splicing was quantified as the percent of RNA transcripts with ψ-Ex [(ψ-Ex/(ψ-Ex+WT))x100] and is shown below each lane.
Human Patient Lymphoblast Cell Line Gm11860, supplied by Coriell Institute for Medical Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/human+patient+lymphoblast+cell+line+gm11860/pmc07367209-31-3-7
Average 90 stars, based on 1 article reviews
human patient lymphoblast cell line gm11860 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
ATCC jurkat, clone e6-1
CFTR c.3718-2477C>T aberrant splicing and correction with a splice-switching antisense oligonucleotide. ( A ) Schematic of the aberrant splicing caused by the CFTR c.3718-2477C>T mutation in intron 22. The C>T mutation creates a de novo 5′ splice site resulting in the insertion into the mRNA of an 84 nucleotide pseudoexon (ψ-Ex) that has an in-frame stop codon. An ASO designed to mask the CFTR c.3718-2477C>T de novo splice site redirects splicing to the canonical splice site, restoring wild-type (WT) mRNA. ( B ) Sequence alignment of ASO-ψ to the ψ-Ex 5′ splice site found in CFTR c.3718-2477C>T. ( C ) RT-PCR analysis of CFTR splicing in a <t>lymphoblast</t> cell line from a CF patient homozygous for the CFTR c.3718-2477C>T mutation following transfection with vehicle only (–), a control, non-targeted ASO (ASO-C) or ASO-ψ targeting the ψ-Ex 5′ splice site. Cells were untreated (−) or treated (+) with puromycin before RNA isolation. GAPDH was analyzed as a control for total cellular RNA abundance. Splicing was quantified as the percent of RNA transcripts with ψ-Ex [(ψ-Ex/(ψ-Ex+WT))x100] and is shown below each lane.
Jurkat, Clone E6 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/Jurkat%2C+Clone+E6-1/custom%40tib-152%4032023489
Average 99 stars, based on 1 article reviews
jurkat, clone e6-1 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

86
Creative Biolabs mouse glioma cell line gl261
CFTR c.3718-2477C>T aberrant splicing and correction with a splice-switching antisense oligonucleotide. ( A ) Schematic of the aberrant splicing caused by the CFTR c.3718-2477C>T mutation in intron 22. The C>T mutation creates a de novo 5′ splice site resulting in the insertion into the mRNA of an 84 nucleotide pseudoexon (ψ-Ex) that has an in-frame stop codon. An ASO designed to mask the CFTR c.3718-2477C>T de novo splice site redirects splicing to the canonical splice site, restoring wild-type (WT) mRNA. ( B ) Sequence alignment of ASO-ψ to the ψ-Ex 5′ splice site found in CFTR c.3718-2477C>T. ( C ) RT-PCR analysis of CFTR splicing in a <t>lymphoblast</t> cell line from a CF patient homozygous for the CFTR c.3718-2477C>T mutation following transfection with vehicle only (–), a control, non-targeted ASO (ASO-C) or ASO-ψ targeting the ψ-Ex 5′ splice site. Cells were untreated (−) or treated (+) with puromycin before RNA isolation. GAPDH was analyzed as a control for total cellular RNA abundance. Splicing was quantified as the percent of RNA transcripts with ψ-Ex [(ψ-Ex/(ψ-Ex+WT))x100] and is shown below each lane.
Mouse Glioma Cell Line Gl261, supplied by Creative Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymphoblast+cell+line/b+cell+human+like+line+lymphoblast/pm41082941-61-0-6
Average 86 stars, based on 1 article reviews
mouse glioma cell line gl261 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


ADCP activity of sabatolimab in vitro . (A) THP-1 cells (TIM-3 sufficient, control, or TIM-3 deficient, KO) were cultured for 1 hour with Raji TIM-3 o.e. cells and treated with different concentrations of sabatolimab or hIgG4 isotype control in duplicates. ADCP was determined by flow cytometric analysis as % of CFSE + CD11c + cells. Plots depict means ± SD for each condition. (B) THP-1 cells (TIM-3 sufficient, control, or TIM-3 deficient, KO) cultured as in A with with Raji hTIM-3 o.e. cells were treated with sabatolimab or hIgG4 isotype control, with Latrunculin A or Fc-blocking antibody added to some of the wells in duplicates. ADCP was determined by flow cytometric analysis as % of CFSE + CD11c + cells. Plots depict means ± SD for each condition. (C,D) Macrophages differentiated from PBMC-isolated monocytes were cultured for 4 hours with CFSE-labeled leukemia cells (HNT-34, in C or SKM-1, in D) and treated with different concentrations of sabatolimab or hIgG4 isotype control in duplicates. ADCP was determined by flow cytometric analysis as % of CFSE + CD11c + cells. Plots depict means ± SD for each condition. Two separate donors are shown for each cell line. Asterisks mark statistically significant P values between sabatolimab- and isotype control-treated samples ( T test * P < 0.05, ** P < 0.005, *** P < 0.001).

Journal: Immunotherapy Advances

Article Title: Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor

doi: 10.1093/immadv/ltac019

Figure Lengend Snippet: ADCP activity of sabatolimab in vitro . (A) THP-1 cells (TIM-3 sufficient, control, or TIM-3 deficient, KO) were cultured for 1 hour with Raji TIM-3 o.e. cells and treated with different concentrations of sabatolimab or hIgG4 isotype control in duplicates. ADCP was determined by flow cytometric analysis as % of CFSE + CD11c + cells. Plots depict means ± SD for each condition. (B) THP-1 cells (TIM-3 sufficient, control, or TIM-3 deficient, KO) cultured as in A with with Raji hTIM-3 o.e. cells were treated with sabatolimab or hIgG4 isotype control, with Latrunculin A or Fc-blocking antibody added to some of the wells in duplicates. ADCP was determined by flow cytometric analysis as % of CFSE + CD11c + cells. Plots depict means ± SD for each condition. (C,D) Macrophages differentiated from PBMC-isolated monocytes were cultured for 4 hours with CFSE-labeled leukemia cells (HNT-34, in C or SKM-1, in D) and treated with different concentrations of sabatolimab or hIgG4 isotype control in duplicates. ADCP was determined by flow cytometric analysis as % of CFSE + CD11c + cells. Plots depict means ± SD for each condition. Two separate donors are shown for each cell line. Asterisks mark statistically significant P values between sabatolimab- and isotype control-treated samples ( T test * P < 0.05, ** P < 0.005, *** P < 0.001).

Article Snippet: The Raji human lymphoblast-like cell line, established from a Burkitt’s lymphoma of the left maxilla of an 11-year-old black male [ ], was obtained from Deutsche Sammlung von Mikrooganismen Zellkulturen (DSMZ, Braunschweig, Germany) and engineered to stably express the human TIM-3 at Trenzyme (Konstanz, Germany).

Techniques: Activity Assay, In Vitro, Control, Cell Culture, Blocking Assay, Isolation, Labeling

Differentially expressed proteins (DEP) identified in TK6 cells exposed to 4-nitroanthranilic acid. a A total of 1078 DEPs that differentially expressed compared to control groups were identified based on a log 2 fold change of ≥2. Effects of treatment time are greater than that of dose. b A total of 168 specific DEPs that differentially expressed compared to other groups were further extracted from the 420 DEPs in 24 h 800 μg/mL group based on a log 2 fold change of ≥1

Journal: Genes and Environment

Article Title: Weight of evidence approach using a TK gene mutation assay with human TK6 cells for follow-up of positive results in Ames tests: a collaborative study by MMS/JEMS

doi: 10.1186/s41021-021-00179-1

Figure Lengend Snippet: Differentially expressed proteins (DEP) identified in TK6 cells exposed to 4-nitroanthranilic acid. a A total of 1078 DEPs that differentially expressed compared to control groups were identified based on a log 2 fold change of ≥2. Effects of treatment time are greater than that of dose. b A total of 168 specific DEPs that differentially expressed compared to other groups were further extracted from the 420 DEPs in 24 h 800 μg/mL group based on a log 2 fold change of ≥1

Article Snippet: The human lymphoblast cell line TK6 was purchased from the Japanese Collection of Research Bioresources cell bank and the American Type Culture Collection.

Techniques: Control

Target gene ontology analysis for TK6 cells exposed to 4-nitroanthranilic acid for 24 h. Whereas no significance was found in GO:0006974 (cellular response to DNA damage stimulus), GO:0006281 (DNA repair), and GO:0006979 (response to oxidative stress), statistically significance was found in GO:0008631 ~ intrinsic apoptotic signaling pathway in response to oxidative stress among DEPs in 24 h 800 μg/mL group and specific DEPs in 24 h 800 μg/mL group, indicating involvement with oxidative stress

Journal: Genes and Environment

Article Title: Weight of evidence approach using a TK gene mutation assay with human TK6 cells for follow-up of positive results in Ames tests: a collaborative study by MMS/JEMS

doi: 10.1186/s41021-021-00179-1

Figure Lengend Snippet: Target gene ontology analysis for TK6 cells exposed to 4-nitroanthranilic acid for 24 h. Whereas no significance was found in GO:0006974 (cellular response to DNA damage stimulus), GO:0006281 (DNA repair), and GO:0006979 (response to oxidative stress), statistically significance was found in GO:0008631 ~ intrinsic apoptotic signaling pathway in response to oxidative stress among DEPs in 24 h 800 μg/mL group and specific DEPs in 24 h 800 μg/mL group, indicating involvement with oxidative stress

Article Snippet: The human lymphoblast cell line TK6 was purchased from the Japanese Collection of Research Bioresources cell bank and the American Type Culture Collection.

Techniques:

Possible mechanisms of oxidative stress produced by the redox reaction of amino- and nitro compounds in human TK6 cells

Journal: Genes and Environment

Article Title: Weight of evidence approach using a TK gene mutation assay with human TK6 cells for follow-up of positive results in Ames tests: a collaborative study by MMS/JEMS

doi: 10.1186/s41021-021-00179-1

Figure Lengend Snippet: Possible mechanisms of oxidative stress produced by the redox reaction of amino- and nitro compounds in human TK6 cells

Article Snippet: The human lymphoblast cell line TK6 was purchased from the Japanese Collection of Research Bioresources cell bank and the American Type Culture Collection.

Techniques: Produced

CFTR c.3718-2477C>T aberrant splicing and correction with a splice-switching antisense oligonucleotide. ( A ) Schematic of the aberrant splicing caused by the CFTR c.3718-2477C>T mutation in intron 22. The C>T mutation creates a de novo 5′ splice site resulting in the insertion into the mRNA of an 84 nucleotide pseudoexon (ψ-Ex) that has an in-frame stop codon. An ASO designed to mask the CFTR c.3718-2477C>T de novo splice site redirects splicing to the canonical splice site, restoring wild-type (WT) mRNA. ( B ) Sequence alignment of ASO-ψ to the ψ-Ex 5′ splice site found in CFTR c.3718-2477C>T. ( C ) RT-PCR analysis of CFTR splicing in a lymphoblast cell line from a CF patient homozygous for the CFTR c.3718-2477C>T mutation following transfection with vehicle only (–), a control, non-targeted ASO (ASO-C) or ASO-ψ targeting the ψ-Ex 5′ splice site. Cells were untreated (−) or treated (+) with puromycin before RNA isolation. GAPDH was analyzed as a control for total cellular RNA abundance. Splicing was quantified as the percent of RNA transcripts with ψ-Ex [(ψ-Ex/(ψ-Ex+WT))x100] and is shown below each lane.

Journal: Nucleic Acids Research

Article Title: Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells

doi: 10.1093/nar/gkaa490

Figure Lengend Snippet: CFTR c.3718-2477C>T aberrant splicing and correction with a splice-switching antisense oligonucleotide. ( A ) Schematic of the aberrant splicing caused by the CFTR c.3718-2477C>T mutation in intron 22. The C>T mutation creates a de novo 5′ splice site resulting in the insertion into the mRNA of an 84 nucleotide pseudoexon (ψ-Ex) that has an in-frame stop codon. An ASO designed to mask the CFTR c.3718-2477C>T de novo splice site redirects splicing to the canonical splice site, restoring wild-type (WT) mRNA. ( B ) Sequence alignment of ASO-ψ to the ψ-Ex 5′ splice site found in CFTR c.3718-2477C>T. ( C ) RT-PCR analysis of CFTR splicing in a lymphoblast cell line from a CF patient homozygous for the CFTR c.3718-2477C>T mutation following transfection with vehicle only (–), a control, non-targeted ASO (ASO-C) or ASO-ψ targeting the ψ-Ex 5′ splice site. Cells were untreated (−) or treated (+) with puromycin before RNA isolation. GAPDH was analyzed as a control for total cellular RNA abundance. Splicing was quantified as the percent of RNA transcripts with ψ-Ex [(ψ-Ex/(ψ-Ex+WT))x100] and is shown below each lane.

Article Snippet: The human patient lymphoblast cell line (GM11860; Coriell Institute) was grown in RPMI media supplemented with 15% fetal bovine serum (FBS).

Techniques: Mutagenesis, Sequencing, Reverse Transcription Polymerase Chain Reaction, Transfection, Control, Isolation